Story perspectives
Biden's Policies Cut Insulin Costs for Medicare Beneficiaries
3/24/2026
1 of 1
Story summary
- A study finds that policies enacted during President Joe Biden's administration reduced insulin prices for Medicare beneficiaries.
- By 2023, 75% of beneficiaries paid $35 or less monthly, up from 48% in 2019.
- Out-of-pocket costs fell from over $50 to about $22, with state costs ranging from just over $10 to over $31.
- The Inflation Reduction Act of 2022 capped insulin prices for Medicare Part D, effective January 2023.
